https://www.selleckchem.com/pr....oducts/bevacizumab.h
Products of some of these genes have been implicated in expansion of hematopoietic stem/progenitor cells in vitro or in vivo.Crosstalk between the estrogen receptors and the receptor tyrosine kinases, including vascular endothelial growth factor receptor type II (VEGFR2), is a key mechanism in breast cancer resistance to antiestrogen therapy with tamoxifen. A high level of VEGFR2 expression in a tumor serves as a marker of tamoxifen resistance. The tamoxifen efficacy prognostic value of functional polymorphisms in the VEGFR2/KDR gen
Like
Comment
Share
